Pilot production payment for LabTech
Friday, 12 September, 2008
LabTech Systems (ASX: LBT) has sent pilot production units of its MicroStreak technology to partner bioMérieux, triggering a $1.74 million milestone payment.
LabTech Systems signed an exclusive license agreement with bioMérieux last year. The French diagnostics giant will market the technology under its PREVI Isola brand.
The technology is a high-speed robotic platform for agar plate streaking in microbiology and pathology labs.
This payment brings the total revenue from the agreement to $6.67 million.
The PREVI Isola will be on sale later this year. LabTech Systems also expects royalty payments to begin from January 1 next year.
Towards the next generation of vision implants
An ultrasmall implant, with electrodes the size of a single neuron that can remain intact in the...
One-two punch treatment knocks out acute myeloid leukaemia
Researchers paired venetoclax, a current standard-of-care anticancer drug for acute myeloid...
Researchers find the 'switch' that deactivates brown fat
Researchers have found a protein that is responsible for turning off brown fat activity, in a...